Phase I first-in-human study of RTA 1701.
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2018
At a glance
- Drugs RTA 1701 (Primary)
- Indications Autoimmune disorders; Inflammation
- Focus Adverse reactions; First in man
- 09 Apr 2018 New trial record
- 03 Apr 2018 According to the Reata Pharmaceuticals media release, this trial expects to initiate in 2018 and initial results are expected in first half of 2019.